2015
DOI: 10.1039/c4cc08515a
|View full text |Cite
|
Sign up to set email alerts
|

A mild TCEP-based para-azidobenzyl cleavage strategy to transform reversible cysteine thiol labelling reagents into irreversible conjugates

Abstract: It has recently emerged that the succinimide linkage of a maleimide thiol addition product is fragile, which is a major issue in fields where thiol functionalisation needs to be robust. Herein we deliver a strategy that generates selective cysteine thiol labelling reagents, which are stable to hydrolysis and thiol exchange.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
35
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 43 publications
(36 citation statements)
references
References 30 publications
(16 reference statements)
1
35
0
Order By: Relevance
“…Irreversible cysteine modification using dibromo‐1,2‐dihydro‐pyridazine‐3,6‐diones was made possible by using p ‐azidobenzyl as a N ‐protection group such as in 111 . This feature allowed post‐conjugative TCEP‐mediated N ‐deprotection, yielding a thiol resistant N ‐unsubstituted adduct (Scheme ) …”
Section: Other Chemical Approaches For Maleimide‐like Bioconjugationmentioning
confidence: 99%
See 2 more Smart Citations
“…Irreversible cysteine modification using dibromo‐1,2‐dihydro‐pyridazine‐3,6‐diones was made possible by using p ‐azidobenzyl as a N ‐protection group such as in 111 . This feature allowed post‐conjugative TCEP‐mediated N ‐deprotection, yielding a thiol resistant N ‐unsubstituted adduct (Scheme ) …”
Section: Other Chemical Approaches For Maleimide‐like Bioconjugationmentioning
confidence: 99%
“…The DBPD platform has been considerably explored in the generation of ADCs, antibody conjugates, antibody directed photosensitizers, protein‐protein conjugates and targeted nanotherapeutics . A DBPD reagent incorporating a terminal alkyne and cyclooctyne probe was used to accomplish complete rebridging of Trastuzumab (4:1 ratio of PD‐to‐antibody).…”
Section: Other Chemical Approaches For Maleimide‐like Bioconjugationmentioning
confidence: 99%
See 1 more Smart Citation
“…A further development of this work involves a strategy for rendering the conjugates resistant to thiol exchange . On the basis of the previous observation that reagents with unsubstituted nitrogen atoms within the ring were not reactive at higher than physiological pH, Maruani et al.…”
Section: Maleimidesmentioning
confidence: 99%
“…In proteins, disulfide bonds are more common than free cysteines, and disulfide reduction followed by rebridging bioconjugation offers another approach for chemoselective modification of proteins and is especially attractive for functionalization of immunoglobulin G (IgG), an antibody that has four reducible interchain disulfides but no free cysteine [25][26][27][28] . Many reagents, including bromomaleimides 29,30 , bromopyridazinediones 27,[31][32][33] , bis-sulfones and allyl sulfones 24,26,34 , and divinylpyrimidine 28 , have been developed for such applications. Nevertheless, seldom of them meet the requirements of simplicity, robustness, and high efficiency.…”
mentioning
confidence: 99%